Last reviewed · How we verify
GSK's investigational vaccine 692342 — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
GSK's investigational vaccine 692342 (GSK's investigational vaccine 692342) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GSK's investigational vaccine 692342 TARGET | GSK's investigational vaccine 692342 | GlaxoSmithKline | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GSK's investigational vaccine 692342 CI watch — RSS
- GSK's investigational vaccine 692342 CI watch — Atom
- GSK's investigational vaccine 692342 CI watch — JSON
- GSK's investigational vaccine 692342 alone — RSS
Cite this brief
Drug Landscape (2026). GSK's investigational vaccine 692342 — Competitive Intelligence Brief. https://druglandscape.com/ci/gsk-s-investigational-vaccine-692342. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab